Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.37 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.37 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | POLA1 | P09884 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2481579 | 1.00 | TSHR (0.47) | TSHRLMNAALDH1A1TDP1L3MBTL1 | |
| SCHEMBL3125935 | 0.95 | TSHR (0.42) | TSHRLMNAALDH1A1TDP1L3MBTL1 | |
| SCHEMBL15058855 | 0.93 | TSHR (0.54) | TSHRLMNAALDH1A1TDP1L3MBTL1 | |
| SCHEMBL8434072 | 0.91 | TSHR (0.52) | TSHRLMNAALDH1A1TDP1L3MBTL1 | |
| SCHEMBL7032690 | 0.91 | TSHR (0.39) | TSHRLMNAALDH1A1TDP1L3MBTL1 | |
| SCHEMBL3698504 | 0.91 | EPHX2 (0.51) | TSHRLMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL13284465 | 0.91 | EPHX2 (0.51) | TSHRLMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL3689996 | 0.91 | EPHX2 (0.51) | TSHRLMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL3707665 | 0.91 | EPHX2 (0.51) | TSHRLMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL2506509 | 0.91 | TSHR (0.39) | TSHRLMNAALDH1A1TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11420926-B2 | Methods of making olefinic E- and Z-isomers | VERBIO VEREINIGTE BIOENERGIE AG (DE) | 2022-08-23 | — | — | US | disclosed |
| US-20210122697-A1 | METHODS OF MAKING OLEFINIC E- AND Z-ISOMERS | VERBIO SE (DE) | 2021-04-29 | — | — | US | disclosed |
| EP-3630741-A1 | METHODS OF MAKING OLEFINIC E- AND Z-ISOMERS | Verbio Vereinigte Bioenergie AG (DE) | 2020-04-08 | — | — | EP | disclosed |
| WO-2018220088-A1 | METHODS OF MAKING OLEFINIC E- AND Z-ISOMERS | XIMO AG (CH) | 2018-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11420926-B2 | Methods of making olefinic E- and Z-isomers | SQLE, OXER1, POR | TSHR 4056/4885LMNA 2664/4885ALDH1A1 325/4885 |
| US-20210122697-A1 | METHODS OF MAKING OLEFINIC E- AND Z-ISOMERS | SQLE, OXER1, POR | TSHR 4056/4885LMNA 2664/4885ALDH1A1 325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.